Skip to content
Peptigraph home

Tirzepatide for Fertility: What the Evidence Shows

What human and animal studies show about Tirzepatide for fertility, how strong that evidence is, and what is still unproven.

Medically reviewed by Juan Pablo Frías, MD · · DisclosureGLP-1 / GIP dual agonistUpdated
Strongest evidence
None graded
no study with an outcome for fertility (PubMed search, 2 Oct 2026)
Human studies
None found
with an outcome for fertility, in our evidence file (PubMed search, 2 Oct 2026)
Animal studies
None found
with an outcome for fertility, in our evidence file (PubMed search, 2 Oct 2026)

Evidence for fertility

None of the study abstracts we summarised for Tirzepatide reported an outcome for fertility (PubMed search, 2 Oct 2026). Claims that it helps with fertility are unproven.

How strong is it?

Strongest evidence:No graded study for fertility (PubMed search, 2 Oct 2026)

A human randomized trial outweighs any number of animal studies. Animal and cell results show a mechanism worth testing, not that it works in people.

Pregnancy and fertility: the label's warnings

MedlinePlus defines infertility as not becoming pregnant after frequent, unprotected sex for one year or longer, or six months if you are 35 or older.[16]

The Zepbound label says the drug may cause fetal harm and should be discontinued when pregnancy is recognised.[17]

The same label adds that weight loss offers no benefit to a pregnant patient.[17]

Mounjaro's label says that in pregnant rats given tirzepatide during organogenesis, fetal growth reductions and fetal abnormalities occurred; this is animal data.[18]

Contraception is the practical fertility issue

The Zepbound label says the drug may reduce the efficacy of oral hormonal contraceptives through delayed gastric emptying. It advises a non-oral method, or a barrier method added, for 4 weeks after initiation and after each dose escalation.[17]

The label says hormonal contraceptives that are not administered orally should not be affected.[17]

Fertility effects in animals and any trials

In rat fertility and early embryonic development studies, the label reports no effects of tirzepatide on sperm morphology, among other measures.[17]

A review lists polycystic ovary syndrome among the common comorbidities where promising data suggest benefits with these drugs. It is not a tirzepatide fertility trial.[19]

Other peptides people research for fertility

Common questions

Does Tirzepatide help with fertility?

None of the studies we summarised for Tirzepatide (PubMed search, 2 Oct 2026) measured an outcome for fertility. Treat claims that it helps with fertility as unproven.

Is Tirzepatide approved for fertility?

Tirzepatide is FDA approved (Mounjaro, Zepbound). Which conditions that approval covers is set by the label; use for anything else is off-label.

Does tirzepatide affect fertility?

No human fertility study is cited here. The label's rat studies reported no fertility effects, and its human concern is that the drug may weaken oral contraceptives.[17]

Can you take tirzepatide while trying to conceive or pregnant?

The Zepbound label says to discontinue the drug when pregnancy is recognised, because it may cause fetal harm.[17]

Does tirzepatide make birth control less effective?

For oral hormonal contraceptives it may, according to the label, which advises a non-oral or added barrier method for 4 weeks after initiation and after each dose escalation.[17]

More on Tirzepatide

Sources

  1. 1PubMed search: tirzepatide[ti] AND (SURMOUNT[tiab] OR SURPASS[tiab]) AND randomized controlled trial[pt] (93 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  2. 2PubMed search: tirzepatide[ti] AND (SURPASS-2 OR SURPASS-3 OR SURPASS-4 OR SURPASS-5 OR "versus semaglutide" OR "SURPASS-CVOT" OR dulaglutide) (143 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  3. 3PubMed search: tirzepatide[ti] AND (steatohepatitis OR NASH OR "heart failure" OR HFpEF OR "preserved ejection" OR cardiovascular) (410 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  4. 4PubMed search: tirzepatide[ti] AND (SURPASS-2 OR SURPASS-3 OR SURPASS-1 OR SURPASS-5 OR "SURPASS J-mono") AND randomized controlled trial[pt] (24 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  5. 5PubMed search: tirzepatide[ti] AND (steatohepatitis OR "heart failure" OR "SUMMIT" OR "SYNERGY-NASH" OR "phase 2") AND randomized controlled trial[pt] (21 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  6. 6PubMed search: tirzepatide[tiab] AND (meta-analysis[pt] OR systematic review[pt]) AND (weight OR glycemic OR HbA1c OR obesity) (178 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  7. 7PubMed search: tirzepatide[tiab] AND (pharmacokinetic*[tiab] OR half-life[tiab]) AND humans[mh] (49 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  8. 8PubMed search: tirzepatide[ti] AND (insulin degludec OR "SURPASS-3") AND "type 2 diabetes"[ti] AND randomized controlled trial[pt] (8 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  9. 9PubMed search: tirzepatide[ti] AND (cardiovascular outcomes OR "SURPASS-CVOT" OR "major adverse") (228 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  10. 10PubMed search: tirzepatide[tiab] AND (depression OR anxiety OR ADHD OR osteoporosis OR "bone mineral" OR menopause OR "rheumatoid" OR arthritis OR testosterone) (121 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  11. 11PubMed search: tirzepatide[tiab] AND ("body composition"[tiab] OR "lean mass"[tiab] OR "visceral fat"[tiab] OR "fat mass"[tiab]) AND humans[mh] (91 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  12. 12PubMed search: tirzepatide[tiab] AND (blood pressure[tiab] OR cholesterol[tiab] OR lipid*[tiab]) AND (randomized controlled trial[pt] OR meta-analysis[pt]) (58 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  13. 13PubMed search: tirzepatide[tiab] AND (SURPASS-CVOT OR "cardiovascular events" ) AND "dulaglutide"[tiab] AND randomized controlled trial[pt] (6 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  14. 14PubMed search: tirzepatide[tiab] AND (depression[tiab] OR anxiety[tiab] OR "mental health"[tiab] OR ADHD[tiab] OR "binge eating"[tiab]) AND (randomized controlled trial[pt] OR clinical trial[pt]) (3 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  15. 15PubMed search: tirzepatide[tiab] AND (menopaus*[tiab] OR PCOS[tiab] OR "polycystic"[tiab] OR testosterone[tiab] OR hypogonadism[tiab]) (55 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  16. 16medlineplus.gov pagemedlineplus.gov · web pagemedlineplus.gov
  17. 17ZEPBOUND prescribing information (FDA label)FDA label, DailyMed · current labeldailymed.nlm.nih.govAccessed 2 Oct 2026
  18. 18MOUNJARO prescribing information (FDA label)FDA label, DailyMed · current labeldailymed.nlm.nih.govAccessed 2 Oct 2026
  19. 19The pleiotropic effects of glucagon-like peptide-1 receptor agonists in patients with metabolic dysfunction-associated steatohepatitis: a review for gastroenterologists.Expert opinion on investigational drugs · 2025PMID 40016997Accessed 2 Oct 2026

Found an error? Report a correction.